ReachMD
Be part of the knowledge.™Approaches to Utilizing Bone-targeting Therapies in mBC
Project Oncology®Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Project Oncology®Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Project Oncology®Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
What to Know About PARP Inhibitors for Advanced Ovarian Cancer
Project Oncology®What to Know About PARP Inhibitors for Advanced Ovarian Cancer
How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer
Project Oncology®How to Tailor Treatment Plans for Patients with Recurrent Ovarian Cancer
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE Live BroadcastRevolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 02, 2023
06:30 PM - 07:30 PM PDT
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE Live BroadcastRevolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
October 09, 2023
12:00 PM - 01:00 PM EDT
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
CME/CEChallenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
CME/CEImproving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Medical Industry FeatureExamining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Medical Industry FeaturePathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Medical Industry FeatureExperts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Medical Industry FeatureImproving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Medical Industry FeatureImproving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Medical Industry FeatureInvestigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
news.weill.cornell.edu
09/29/2023- bcm.edu
09/28/2023
- miragenews.com
09/28/2023
- prnewswire.com
09/27/2023
- news.unchealthcare.org
09/27/2023
- medicalxpress.com
09/27/2023